MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MH-19-0010512
Trois Biotech Private Limited
Trois Biotech Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹3,305
▼ 100% YoY
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2025
Balance sheet date
Last AGM
30 Sep 2025
Annual general meeting
About Trois Biotech Private Limited
Data last updated:
Trois Biotech Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 March 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2020PTC338789. Its GSTIN is 27AAHCT8130A1ZL (Maharashtra).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Hiren Pravin Doshi and Dhiren Chandulal Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Floor – Grd Plot – 262, Sant Tukaram Marg Chinchbunder Mumbai., Maharashtra, India – 400009.
Trois Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0010512).
Company details
CIN U24100MH2020PTC338789
Registration Number 338789
Incorporation Date 13 March 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0010512
Recognitions & Rankings of Trois Biotech
Contact details
Trois Biotech Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFloor – Grd Plot – 262, Sant Tukaram Marg Chinchbunder Mumbai., Maharashtra, India – 400009
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Trois Biotech Private Limited, buy the company report.
Comprehensive company report
Trois Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Trois Biotech is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Trois Biotech Private Limited, buy the company report.
Financials of Trois Biotech Private Limited
FY 2025 filings availableTrois Biotech Private Limited reported revenue of ₹3,305 (down 100% YoY) for FY 2024.
Revenue · FY 2024
₹3,305 ▼ 100%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▼ 86%
Revenue has declined at a compounded annual rate (CAGR) of 86% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Trois Biotech Private Limited, buy the company report.
Board of directors of Trois Biotech Private Limited
Trois Biotech has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hiren Pravin Doshi | Director | 13 Mar 2020 | 6 Years 7 Months | Current |
| Dhiren Chandulal Shah | Director | 13 Mar 2020 | 6 Years 7 Months | Current |
| Dhairya Dhiren Shah Also directs: Eastern Chemicals (Mumbai) Private Limited | Director | 13 Mar 2020 | 6 Years 7 Months | Current |
Auditor
Trois Biotech Private Limited is audited by POPATLAL JAIN AND CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| POPATLAL JAIN AND CO | FY 2023 | 107977W |
Shareholding
The shareholding of Trois Biotech Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Trois Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Trois Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Trois Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Trois Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCT8130A1ZL | Maharashtra | Active | 20 Aug 2020 |
To see the full GST registrations and return filing status of Trois Biotech Private Limited, buy the company report.
Recent activity
Trois Biotech Private Limited has 11 board changes on record since 2020: 7 appointments and 4 cessations. The latest: Dilip Dinesh Ketiwalla ceased to be Additional Director on 06 Feb 2025.
AGM
Trois Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Trois Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Dilip Dinesh Ketiwalla ceased to be Additional Director.
Ceased
Jinesh Bhupat Doshi ceased to be Director.
Ceased
Laxman Anandrao Pawar ceased to be Director.
Ceased
Fredun Nariman Medhora ceased to be Director.
Appointed
Dilip Dinesh Ketiwalla was appointed as Additional Director.
Appointed
Dhairya Dhiren Shah was appointed as Director.
Appointed
Dhiren Chandulal Shah was appointed as Director.
Appointed
Fredun Nariman Medhora was appointed as Director.
Appointed
Hiren Pravin Doshi was appointed as Director.
Appointed
Jinesh Bhupat Doshi was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Trois Biotech is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 March 2020 (6+ years old) and is registered under CIN U24100MH2020PTC338789.
Trois Biotech has 3 current directors:
- Hiren Pravin Doshi - Director
- Dhiren Chandulal Shah - Director
- Dhairya Dhiren Shah - Director
The latest financial statements of Trois Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Trois Biotech is 27AAHCT8130A1ZL, registered in Maharashtra.
The CIN (Corporate Identification Number) of Trois Biotech is U24100MH2020PTC338789. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Trois Biotech was incorporated on 13 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Dilip Dinesh Ketiwalla ceased to be Additional Director on 06 Feb 2025. Jinesh Bhupat Doshi ceased to be Director on 06 Feb 2025. Laxman Anandrao Pawar ceased to be Director on 06 Feb 2025. Trois Biotech has 11 board changes on record in total.
Yes, Trois Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0010512).
The registered office of Trois Biotech is at Floor – Grd Plot – 262, Sant Tukaram Marg Chinchbunder Mumbai., Maharashtra, India – 400009.
Trois Biotech operates in the pharma industry, in the drug formulation and development segment.